Versant Venture Capital III L.P. 13D and 13G filings for Skye Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-28 4:17 pm Purchase | 2023-08-18 | 13G | Skye Bioscience, Inc. SKYE | Versant Venture Capital III L.P. | 2,530,949 19.700% | 2,530,949 (New Position) | Filing |